Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 5971 AL 5985

Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort

Wattmo C, Wallin AK, Minthon L.

BMC Neurol. 2012 Nov 5;12:134. doi: 10.1186/1471-2377-12-134.

Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer´s disease - protocol for a controlled, randomized double-blinded trial

Egefjord L, Gejl M, Møller A, Brændgaard H, Gottrup H, Antropova O, Møller N, Poulsen HE, Gjedde A, Brock B, Rungby J.

Dan Med J. 2012 Oct;59(10):A4519.

Telomere shortening and Alzheimer's disease

Cai Z, Yan LJ, Ratka A.

Neuromolecular Med. 2013 Mar;15(1):25-48. doi: 10.1007/s12017-012-8207-9. Epub 2012 Nov 16.

New horizons for diagnostics and therapeutic applications of graphene and graphene oxide

Feng L, Wu L, Qu X.

Adv Mater. 2013 Jan 11;25(2):168-86. doi: 10.1002/adma.201203229. Epub 2012 Nov 19.

Practice effects in a longitudinal, multi-center Alzheimer's disease prevention clinical trial

Abner EL, Dennis BC, Mathews MJ, Mendiondo MS, Caban-Holt A, Kryscio RJ, Schmitt FA; PREADViSE Investigators; Crowley JJ; SELECT Investigators.

Trials. 2012 Nov 20;13:217. doi: 10.1186/1745-6215-13-217.

[Nanoparticles for brain delivery of drugs or contrast agents. Application to Alzheimer's disease]

Andrieux K, Couvreur P.

Biol Aujourdhui. 2012;206(3):185-90. doi: 10.1051/jbio/2012019. Epub 2012 Nov 22.

Application of behavior-based ergonomics therapies to improve quality of life and reduce medication usage for Alzheimer's/dementia residents

Mowrey C, Parikh PJ, Bharwani G, Bharwani M.

Am J Alzheimers Dis Other Demen. 2013 Feb;28(1):35-41. doi: 10.1177/1533317512467678. Epub 2012 Nov 29.

[Alzheimer's disease: are non-steroidal anti-inflammatory drugs effective?]

Peters O.

Dtsch Med Wochenschr. 2012 Dec;137(50):2627. doi: 10.1055/s-0032-1329138. Epub 2012 Dec 5.

[Assessment of benefits of drug therapies: memantine for Alzheimer's disease as an example]

Rüther E, Hellweg R, Janetzky W.

Fortschr Neurol Psychiatr. 2012 Dec;80(12):694-9. doi: 10.1055/s-0032-1312976. Epub 2012 Dec 10.

Hemodynamic effects of cholinesterase inhibition in mild Alzheimer's disease

Chaudhary S, Scouten A, Schwindt G, Janik R, Lee W, Sled JG, Black SE, Stefanovic B.

J Magn Reson Imaging. 2013 Jul;38(1):26-35. doi: 10.1002/jmri.23967. Epub 2012 Dec 13.

Cognitive intervention therapy as treatment for behaviour disorders in Alzheimer disease: evidence on efficacy and neurobiological correlations

García-Alberca JM.

Neurologia. 2015 Jan-Feb;30(1):8-15. doi: 10.1016/j.nrl.2012.10.002. Epub 2012 Dec 15.

[Effects of telmisartan on the level of Aβ1-42, interleukin-1β, tumor necrosis factor α and cognition in hypertensive patients with Alzheimer's disease]

Li W, Zhang JW, Lu F, Ma MM, Wang JQ, Suo AQ, Bai YY, Liu HQ.

Zhonghua Yi Xue Za Zhi. 2012 Oct 23;92(39):2743-6.

The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design

Devanand DP, Mintzer J, Schultz S, Sultzer D, de la Pena D, Gupta S, Colon S, Schimming C, Pelton GH, Andrews H, Levin B.

Am J Geriatr Psychiatry. 2012 Apr;20(4):362-73. doi: 10.1097/JGP.0b013e3182110563.

Effects of atorvastatin on cerebral blood flow in middle-aged adults at risk for Alzheimer's disease: a pilot study

Carlsson CM, Xu G, Wen Z, Barnet JH, Blazel HM, Chappell RJ, Stein JH, Asthana S, Sager MA, Alsop DC, Rowley HA, Fain SB, Johnson SC.

Curr Alzheimer Res. 2012 Oct;9(8):990-7. doi: 10.2174/156720512803251075.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias